ClinConnect ClinConnect Logo
Search / Trial NCT06626490

Prospective Follow-up of the Prevision Hip Stem With Comparison of Different Implant Variants

Launched by AESCULAP AG · Oct 2, 2024

Trial Information

Current as of July 01, 2025

Not yet recruiting

Keywords

Patient Reported Outcomes Clinical Performance And Safety Total Hip Arthroplasty Implantation

ClinConnect Summary

This clinical trial is studying the safety and performance of a specific type of hip implant called the Prevision hip stem. It focuses on patients who need a revision total hip replacement, which means they are having surgery to replace a previously placed hip implant. The goal of the study is to see if this new implant works just as well as other options available. The trial is observational, meaning that doctors will monitor patients after their surgery to gather information about their recovery and function.

To participate in this study, patients need to be between 65 and 74 years old and must have had a Prevision hip stem implanted. They also need to provide written consent and be able to attend follow-up appointments to check on their progress. However, patients under 18, those who are pregnant, or individuals in certain dependent situations will not be eligible for this trial. If you qualify and decide to participate, you'll be closely monitored to ensure you are recovering well after your surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Revision hip arthroplasty patients treated with a Prevision hip stem
  • Written patient informed consent
  • Patients are able to attend at follow-up examinations
  • Exclusion Criteria:
  • Patients \< 18 years at surgery
  • Pregnancy at implantation
  • Patients held in a custodial setting
  • Patients in a relationship of dependence on the sponsor, the clinic or the investigator

About Aesculap Ag

Aesculap AG is a prominent global medical device manufacturer specializing in surgical instruments, implants, and innovative healthcare solutions. With a rich history rooted in excellence and innovation, Aesculap AG is dedicated to advancing surgical practices through cutting-edge technology and a commitment to improving patient outcomes. The company collaborates with healthcare professionals and institutions to conduct clinical trials that evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of quality and performance. Through its rigorous research and development initiatives, Aesculap AG aims to contribute significantly to the field of medicine and enhance the standards of surgical care worldwide.

Locations

Hannover, , Germany

Patients applied

0 patients applied

Trial Officials

Henning Windhagen, Prof. Dr.

Principal Investigator

Orthopädische Kliniken im Annastift, MHH

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported